Deutsche Bank’s Yarrow Bioscience YARW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-54
Closed -$169K 4699
2021
Q2
$169K Buy
54
+28
+108% +$111K ﹤0.01% 3878
2021
Q1
$162K Sell
26
-3
-10% -$21.8K ﹤0.01% 3745
2020
Q4
$163K Buy
29
+9
+45% +$56.6K ﹤0.01% 3579
2020
Q3
$121K Buy
20
+6
+43% +$35K ﹤0.01% 3459
2020
Q2
$86K Buy
14
+6
+75% +$40.6K ﹤0.01% 3524
2020
Q1
$81K Hold
8
﹤0.01% 3337
2019
Q4
$131K Hold
8
﹤0.01% 3452
2019
Q3
$130K Sell
8
-5
-38% -$80.7K ﹤0.01% 3412
2019
Q2
$282K Buy
13
+9
+225% +$223K ﹤0.01% 3638
2019
Q1
$106K Sell
4
-4
-50% -$96K ﹤0.01% 4284
2018
Q4
$121K Sell
8
-3
-27% -$67.2K ﹤0.01% 4134
2018
Q3
$396K Buy
11
+7
+175% +$216K ﹤0.01% 3905
2018
Q2
$115K Buy
4
+2
+100% +$77.7K ﹤0.01% 4501
2018
Q1
$310K Buy
+2
New +$243K ﹤0.01% 3972

Other funds holding YARW

Deutsche Bank's YARW Position: Q3 2021 in Review

Deutsche Bank sold out of Yarrow Bioscience (YARW) in Q3 2021, closing a stake of 54 shares — an estimated $169K sold.

Deutsche Bank first reported a position in YARW in Q1 2018 and held it in 14 quarters. The position peaked at $396K in Q3 2018. 58 funds tracked by Wall St. Rank hold YARW as of Q3 2021.

  • Deutsche Bank reported no remaining Yarrow Bioscience position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 54 Yarrow Bioscience shares in Q3 2021, an estimated $169K.
  • Deutsche Bank first reported a position in Yarrow Bioscience in Q1 2018 and held it in 14 quarters.
  • Deutsche Bank's Yarrow Bioscience position peaked at $396K in Q3 2018.
  • 58 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.